Rishabh Chawla joined Gimv in October 2021 as an Associate.
Rishabh has over 3 years of international venture capital experience, most recently at V-Bio Ventures in Ghent.
Rishabh has a PhD in Biochemistry from the Eberhard Karls University of Tübingen, Germany, where he was involved in identifying novel targets and developing novel drugs for therapy resistant cancers and liver regeneration. He also has a MRes in Molecular Medicine from the University of Glasgow, U.K and B.tech (Engineering) in Industrial Biotechnology for VIT-University, India.
